Cancer Institute of New Jersey (CINJ), Gastrointestinal Oncology

Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit

gemcitabine Medicine & Life Sciences
Adenocarcinoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Esophageal Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Carcinoma Medicine & Life Sciences
Radiotherapy Medicine & Life Sciences
Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Profiles

No photo of Usha Malhotra

Usha Malhotra

Person

20052018
No photo of Elizabeth Poplin

Elizabeth Poplin

Person

19822019

Research Output 1986 2019

Effect of Long-Term Mesalamine Therapy on Cancer-Associated Gene Expression in Colonic Mucosa of Patients with Ulcerative Colitis

Bajpai, M., Seril, D., Van Gurp, J., Geng, X., Alvarez, J., Minacapelli, C. D., Gorin, S., Das, K. K., Poplin, E., Cheng, J., Amenta, P. S. & Das, K. M., Mar 15 2019, In : Digestive Diseases and Sciences. 64, 3, p. 740-750 11 p.

Research output: Contribution to journal › Article

Mesalamine
Neoplasm Genes
Ulcerative Colitis
Mucous Membrane
Gene Expression

MiR-206 as a biomarker for response to mesalamine treatment in ulcerative colitis

Minacapelli, C. D., Bajpai, M., Geng, X., Van Gurp, J., Poplin, E., Amenta, P. S., Brant, S. & Das, K. M., Jan 1 2019, In : Inflammatory bowel diseases. 25, 1, p. 78-84 7 p.

Research output: Contribution to journal › Article

Mesalamine
Ulcerative Colitis
Biomarkers
Adenosine A3 Receptors
HT29 Cells
5 Citations (Scopus)

A multicenter phase II study of gemcitabine, capecitabine, and bevacizumab for locally advanced or metastatic biliary tract cancer

Iyer, R. V., Pokuri, V. K., Groman, A., Ma, W. W., Malhotra, U., Iancu, D. M., Grande, C. & Saab, T. B., Jul 1 2018, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 41, 7, p. 649-655 7 p.

Research output: Contribution to journal › Article

gemcitabine
Biliary Tract Neoplasms
Circulating Neoplastic Cells
Survival
Vascular Endothelial Growth Factor A